Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

cnbc.com/2025/05/19/regeneron-pharmaceuticals-to-buy-23andme-for-256-million-including-data.html

Regeneron is acquiring "substantially all" of 23andMe's assets for $256 million following a bankruptcy auction.

This story appeared on cnbc.com, 2025-05-19 14:14:33.
The Entire Business World on a Single Page. Free to Use →